Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-12-20

Clinical Trial Update: Chemoembolization Using Irinotecan in Treating Patients With Liver Metastases From Metastatic Colon or Rectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of chemoembolization with irinotecan for liver metastases from metastatic colon or rectal cancer; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Irinotecan (Irinotecan)

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Liver Metastases, Mucinous Adenocarcinoma of the Colon | Phase 1 | Status: TERMINATED | Results posted: 2021-12-20